Stock RVNC REVANCE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Revance Therapeutics, Inc.

Equities

RVNC

US7613301099

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
2.84 USD -1.56% Intraday chart for Revance Therapeutics, Inc. +4.80% -67.69%
May. 10 Needham Adjusts Price Target on Revance Therapeutics to $12 From $18, Maintains Buy Rating MT
May. 10 Piper Sandler Cuts Price Target on Revance Therapeutics to $11 From $20, Maintains Overweight Rating MT
6393.462CBMLJNazmjYzAipHzj2H1m1Cc8dTbmmVdRlz7t_0.tNr6VaP7BZqg9eb2s6Ow6waZwiTTxIfj-SIyKyy5zqKvwNA8o7Fd44n_3Q~46df82286e34c8a05f9d6f4eeb771ff1
  1. Stock Market
  2. Equities
  3. RVNC Stock
  4. Charts Revance Therapeutics, Inc.
  5. News Chart